Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 9,817-9,828 of 23,847
Behavioral study icon
CompletedNCT00254462

Atomoxetine for Treating Attention Deficit Hyperactivity Disorder in Young Children

This study exists to explore whether a digital app or remote support tool could improve care and understanding. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

Multiple locations, including Omaha
ADHDBehavioralFrom 5 Years to 6 Years
Countries
United States
Sponsor
University of Nebraska
Condition
ADHD
Drug study icon
CompletedNCT00218543

Atomoxetine for Treating Cocaine Abuse in Adults With Attention Deficit Hyperactivity Disorder (ADHD)

This study exists to compare options and see whether a therapy or guided support program offers something meaningfully different. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

In New York
ADHDDrugA study involving a medication or substance.From 18 Years to 60 Years
Countries
United States
Sponsor
New York State Psychiatric Institute
Condition
ADHD
Drug study icon
CompletedNCT00142961

Atomoxetine for Treating Marijuana-Abusing Adolescents Who Have Attention Deficit Hyperactivity Disorder

This study exists to compare options and see whether a therapy or guided support program offers something meaningfully different. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

In New York
ADHDDrugFrom 14 Years to 21 Years
Countries
United States
Sponsor
New York State Psychiatric Institute
Condition
ADHD
Behavioral study icon
CompletedNCT00176436

Atomoxetine for Treatment of Weight Gain in Olanzapine or Clozapine Patients

This study exists to explore whether a guided support group could improve care and understanding. Researchers are trying to understand what a guided support group could change in day-to-day care and decision-making.

In Catonsville
SchizophreniaBehavioralFrom 18 Years to 65 Years
Countries
United States
Sponsor
University of Maryland, Baltimore
Condition
Schizophrenia
Drug study icon
CompletedNCT00327834

Atomoxetine in the Treatment of Binge Eating disorders

This summary needs review. Please check the official study record and contact the research team for details.

In Cincinnati
Eating disordersDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Lindner Center of HOPE
Condition
Eating disorders
Drug study icon
CompletedNCT02287038

Atomoxetine in Veterans With Comorbid ADHD/PTSD

This study exists to see whether a digital app or remote support tool is workable and worth testing more broadly. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

In Charleston
PTSD, ADHDDrugFrom 20 Years to 60 Years
Countries
United States
Sponsor
VA Office of Research and Development
Condition
PTSD, ADHD
Drug study icon
CompletedNCT03154359

Atomoxetine PBPK-PD Clinical Study

This study exists to explore whether a digital app or remote support tool could improve care and understanding. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

In Kansas City
ADHDDrugFrom 6 Years to 18 Years
Countries
United States
Sponsor
Children's Mercy Hospital Kansas City
Condition
ADHD
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.